Replies to post #363776 on Anavex Life Sciences Corp (AVXL)

[plexrec]

"Characterizing Rare Disease Biology"--good find george !!!! Thanks !

[nidan7500]

Excellent catch & Post Georgejji...

Wednesday 22 June 2022, Christopher Missling
Company: Anavex Life Sciences

Job title: President & Chief Executive Officer

Seminars:
Characterizing Rare Disease Biology in Clinical Studies to Observe Drug Effects in Patient Sub-Populations 11:00 am

Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses Using unsupervised computerized AI analysis to assess large data Correlating genomic analysis with extensive clinical data outcomes and endpoint scales

Details:

Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses

Using unsupervised computerized AI analysis to assess large data

Correlating genomic analysis with extensive clinical data outcomes and endpoint scales

Day: Day One

https://rare-genetic-neurodegenerative-development.com/speaker/christopher-missling-2/

Good luck and GOD bless,

I am going to suggest a simplified version-TITLE for the Dr.M. talk on June 22...
My suggested TITLE IS:

"THIS IS A FOOTBALLL."...Now, I will SPLAIN how it changes the BP-WS game.